|
|
Community-based site networks are becoming a driving force behind improving healthcare equity in clinical trials, while simultaneously increasing enrollment and retention rates. Embedded into their communities, these sites have far greater positive reach. Gain a greater understanding of the paradigm shift created by the utilization of site networks that are driving today's clinical trial success.
|
|
|
|
Clinical, emotional, and logistical complexities of trial participation magnify the importance of flexibility, especially for pediatric patients. DCT Solutions are bringing care into any environment where the patient feels safe and supported. Explore the possibilities and how MRN was able to deliver a Phase 2 trial to a patient at a Ronald McDonald House.
|
|
|
|
Are more women affected by the condition than men? If the answer is 'yes', then this truth should be reflected in the trial data. Clinical trials need to be designed around the population the therapy ultimately aims to treat. See how bringing trials to patients, where they are, increases participation as well as improves real-world data by reaching those who ordinarily wouldn't be able to participate in clinical trials.
|
|
|
|
Go “behind-the-scenes” with MRN's CEO, Stuart Redding, and gain insight into how MRN is successfully able to bring trials to wherever patients live, work, or play. From IMP administration in the home to taking safety lab samples, MRN's capabilities extend across all phases and indications seamlessly.
|
|
|
|
|
MRN Is Presenting & Exhibiting At SCOPE EU!
|
Don't miss us in Barcelona! MRN will be attending and presenting at SCOPE EU. As the market leaders in community-centric Decentralized Clinical Trials (DCTs), this is your opportunity to meet in-person with the MRN Team and learn how we increase enrollment and engagement while accelerating trial timelines by bringing your trials to more patients in more communities. Schedule a meeting time here and visit us at Booth #23.
|
|
|